• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国血友病的发病情况。血友病监测系统项目调查人员。

Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators.

作者信息

Soucie J M, Evatt B, Jackson D

机构信息

National Center for Infectious Diseases, Hematologic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.

出版信息

Am J Hematol. 1998 Dec;59(4):288-94. doi: 10.1002/(sici)1096-8652(199812)59:4<288::aid-ajh4>3.0.co;2-i.

DOI:10.1002/(sici)1096-8652(199812)59:4<288::aid-ajh4>3.0.co;2-i
PMID:9840909
Abstract

An active surveillance system was used to identify all residents with hemophilia in six U.S. states (Colorado, Georgia, Louisiana, Massachusetts, New York, and Oklahoma). A hemophilia case was defined as a person with physician-diagnosed hemophilia A or B and/or a measured baseline factor VIII or IX activity (FA) of 30% or less. Case-finding methods included patient reports from physicians, clinical laboratories, hospitals, and hemophilia treatment centers. Once identified, trained data abstractors collected clinical and outcome data retrospectively from medical records. Among cases identified in 1993-1995, 2,743 were residents of the six states in 1994, of whom 2,156 (79%) had hemophilia A. Of those with available FA measurements, 1,140 (43%) had severe (FA < 1%), 684 (26%) had moderate (FA 1%-5%), and 848 (31%) had mild (FA 6%-30%) disease. The mean and median age was 25.4 and 23 years, respectively. The age-adjusted prevalence of hemophilia in all six states in 1994 was 13.4 cases/100,000 males (10.5 for hemophilia A and 2.9 for B). The prevalence by race/ethnicity was 13.2 cases/100,000 among white, 11.0 among African American, and 11.5 among Hispanic males. Application of age-specific prevalence rates from the six surveillance states to the U.S. population resulted in an estimated national population of 13,320 cases of hemophilia A and 3,640 cases of hemophilia B. For the 10-year period 1982-1991, the average incidence of hemophilia A and B in the hemophilia surveillance system (HSS) states was estimated to be 1 in 5,032 live male births.

摘要

采用主动监测系统识别美国六个州(科罗拉多州、佐治亚州、路易斯安那州、马萨诸塞州、纽约州和俄克拉何马州)所有血友病患者。血友病病例定义为经医生诊断为甲型或乙型血友病的人,和/或测得的基线凝血因子 VIII 或 IX 活性(FA)为 30% 或更低。病例发现方法包括医生、临床实验室、医院和血友病治疗中心提供的患者报告。一旦确定,经过培训的数据提取人员会从医疗记录中回顾性收集临床和结局数据。在 1993 - 1995 年确定的病例中,1994 年有 2743 例是这六个州的居民,其中 2156 例(79%)为甲型血友病。在有 FA 测量值的患者中,1140 例(43%)为重度(FA < 1%),684 例(26%)为中度(FA 1% - 5%),848 例(31%)为轻度(FA 6% - 30%)疾病。平均年龄和中位年龄分别为 25.4 岁和 23 岁。1994 年所有六个州经年龄调整后的血友病患病率为每 10 万男性中有 13.4 例(甲型血友病为 10.5 例,乙型血友病为 2.9 例)。按种族/族裔划分的患病率为:白人每 10 万中有 13.2 例,非裔美国人每 10 万中有 11.0 例,西班牙裔男性每 10 万中有 11.5 例。将六个监测州的年龄特异性患病率应用于美国人口,得出全国估计有 13320 例甲型血友病病例和 3640 例乙型血友病病例。在 1982 - 1991 年的 10 年期间,血友病监测系统(HSS)各州甲型和乙型血友病的平均发病率估计为每 5032 例活产男婴中有 1 例。

相似文献

1
Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators.美国血友病的发病情况。血友病监测系统项目调查人员。
Am J Hematol. 1998 Dec;59(4):288-94. doi: 10.1002/(sici)1096-8652(199812)59:4<288::aid-ajh4>3.0.co;2-i.
2
Assisted reproductive technology surveillance--United States, 2011.辅助生殖技术监测——美国,2011 年。
MMWR Surveill Summ. 2014 Nov 21;63(10):1-28.
3
Secular trends in the prevalence of HIV infection among a population of males with hemophilia, 1988-1997: the Oklahoma Hemophilia Surveillance System.1988 - 1997年血友病男性人群中HIV感染患病率的长期趋势:俄克拉荷马血友病监测系统
J Okla State Med Assoc. 1999 Sep;92(9):462-7.
4
Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.2010 - 2011年美国肌萎缩侧索硬化症的患病率
MMWR Suppl. 2014 Jul 25;63(7):1-14.
5
High school completion rates among men with hemophilia.男性血友病患者的高中完成率。
Am J Prev Med. 2010 Apr;38(4 Suppl):S489-94. doi: 10.1016/j.amepre.2009.12.024.
6
Assisted reproductive technology surveillance -- United States, 2010.辅助生殖技术监测--美国,2010 年。
MMWR Surveill Summ. 2013 Dec 6;62(9):1-24.
7
Prevalence of malignancies among U.S. male patients with haemophilia: a review of the Haemophilia Surveillance System.美国男性血友病患者恶性肿瘤的患病率:对血友病监测系统的回顾。
Haemophilia. 2012 Jul;18(4):532-9. doi: 10.1111/j.1365-2516.2011.02731.x. Epub 2012 Jan 8.
8
Assisted Reproductive Technology Surveillance — United States, 2012.辅助生殖技术监测—美国,2012 年。
MMWR Surveill Summ. 2015 Aug 14;64(6):1-29.
9
Occurrence rates of haemophilia among males in the United States based on surveillance conducted in specialized haemophilia treatment centres.根据在美国专门的血友病治疗中心进行的监测,美国男性血友病的发生率。
Haemophilia. 2020 May;26(3):487-493. doi: 10.1111/hae.13998. Epub 2020 Apr 24.
10
Population-based surveillance of haemophilia and patient outcomes in Indiana using multiple data sources.利用多种数据源对印第安纳州血友病和患者结局进行基于人群的监测。
Haemophilia. 2019 May;25(3):456-462. doi: 10.1111/hae.13734. Epub 2019 Mar 29.

引用本文的文献

1
Modelling US health equity impacts of emicizumab for severe haemophilia A: aggregate distributional cost-effectiveness analysis.评估艾美赛珠单抗对重度甲型血友病的美国健康公平性影响:总体分布成本效益分析
BMJ Open. 2025 Sep 9;15(9):e103112. doi: 10.1136/bmjopen-2025-103112.
2
Missense and nonsense mutations and inhibitor development in patients with hemophilia A and B.血友病A和B患者中的错义突变、无义突变及抑制剂的研发
J Thromb Thrombolysis. 2025 Aug 29. doi: 10.1007/s11239-025-03171-6.
3
Hemosiderin quantification in hemophilic arthropathy using quantitative magnetic resonance imaging.
利用定量磁共振成像对血友病性关节病中的含铁血黄素进行定量分析。
Sci Rep. 2025 Apr 24;15(1):14353. doi: 10.1038/s41598-025-99085-7.
4
Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review.巴西甲型血友病患者的年化出血率:一项系统评价。
Hematol Transfus Cell Ther. 2025 Apr-Jun;47(2):103736. doi: 10.1016/j.htct.2025.103736. Epub 2025 Mar 28.
5
Increased Expression Level of Human Blood Clotting Factor VIII Using NS0 Cell Line as a Host Cells.以NS0细胞系作为宿主细胞提高人凝血因子VIII的表达水平。
Iran J Biotechnol. 2024 Apr 1;22(2):e3772. doi: 10.30498/ijb.2024.409915.3772. eCollection 2024 Apr.
6
Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.利用尿液来源的诱导多能干细胞推进细胞治疗、疾病建模和药物测试中的精准医学。
J Biomed Sci. 2024 May 9;31(1):47. doi: 10.1186/s12929-024-01035-4.
7
Risk of Intracranial Hemorrhage in Persons with Hemophilia A in the United States: Real-World Retrospective Cohort Study Using the ATHNdataset.美国甲型血友病患者颅内出血风险:使用ATHN数据集的真实世界回顾性队列研究
J Blood Med. 2024 Apr 24;15:191-205. doi: 10.2147/JBM.S443380. eCollection 2024.
8
Race and ethnicity reporting and representation in hemophilia clinical trials.血友病临床试验中的种族和民族报告及代表性问题。
Blood Adv. 2024 May 28;8(10):2351-2360. doi: 10.1182/bloodadvances.2024012862.
9
Personalized Prophylaxis with myPKFiT: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients.基于 myPKFiT 的个体化预防治疗:血友病 A 患者真实世界的成本效果分析。
Medicina (Kaunas). 2023 Dec 24;60(1):34. doi: 10.3390/medicina60010034.
10
Race, ethnicity, and immune tolerance induction in hemophilia A in the United States.美国血友病A患者的种族、族裔与免疫耐受诱导
Res Pract Thromb Haemost. 2023 Nov 4;7(8):102251. doi: 10.1016/j.rpth.2023.102251. eCollection 2023 Nov.